We discovered that the ATP6V0B gene from patient plasma EVs could be a highly specific marker for diagnosing pancreatic cancer by validating a pilot cohort of 22 plasma samples (6 healthy, 16 patients including 6 matched tumor tissues). The gene discussed is ATP6V0B; the disease is familial pancreatic carcinoma.